Literature DB >> 8403127

Propofol and chemotherapy emesis.

A Borgeat, O H Wilder-Smith, M Forni.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8403127     DOI: 10.1007/BF03009748

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


× No keyword cloud information.
  5 in total

1.  Subhypnotic doses of propofol possess direct antiemetic properties.

Authors:  A Borgeat; O H Wilder-Smith; M Saiah; K Rifat
Journal:  Anesth Analg       Date:  1992-04       Impact factor: 5.108

2.  Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis.

Authors:  M Marty; P Pouillart; S Scholl; J P Droz; M Azab; N Brion; E Pujade-Lauraine; B Paule; D Paes; J Bons
Journal:  N Engl J Med       Date:  1990-03-22       Impact factor: 91.245

3.  Use of propofol for the prevention of chemotherapy-induced nausea and emesis in oncology patients.

Authors:  C S Scher; D Amar; R H McDowall; S M Barst
Journal:  Can J Anaesth       Date:  1992-02       Impact factor: 5.063

4.  Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients.

Authors:  M G Kris; R J Gralla; L B Tyson; R A Clark; D P Kelsen; L K Reilly; S Groshen; G J Bosl; L A Kalman
Journal:  Cancer       Date:  1985-02-01       Impact factor: 6.860

5.  Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.

Authors:  R J Gralla; L M Itri; S E Pisko; A E Squillante; D P Kelsen; D W Braun; L A Bordin; T J Braun; C W Young
Journal:  N Engl J Med       Date:  1981-10-15       Impact factor: 91.245

  5 in total
  1 in total

Review 1.  Propofol. An update of its use in anaesthesia and conscious sedation.

Authors:  H M Bryson; B R Fulton; D Faulds
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.